You are not logged in.   Log in

Acute Erythroblastic leukemia (M6)

From $1

Please contribute to the site. See the contributor's FAQ for more information.


Erythroleukemia (or "acute Di Guglielmo syndrome") is a rare form of acute myeloid leukemia (AML) where the myeloproliferation is of erythrocyte precursors. It is defined at type "M6" under the FAB classification. M6 or erythroleukemia is rare and difficult to diagnose. More than 30-50% of the nucleated marrow cells are abnormal nucleated red blood cells.

Sample Cases

Click here for instructions on how to download the free FCS Express Reader to view and manipulate the sample cases.

Case Name
(click on case name to open)
Comments  Size
M6-1 An example of M6 AML 10.5 Mb

Erythroleukemia is predominantly a disease of adults. It comprises 5-6% of cases of AML. Pure erythroid leukemiais extremely rare and can occur at any age. Occasional cases of CML will transform in to AML-M6.

Possible causes

The cause is unknown.


The leukemic red cells are frequently bizarre with extreme dysplastic features including: giant forms, multinucleation, cytoplasmic vacuolization, cytoplasmic buds, and megaloblastoid changes.  Cytoplasmic pseudopods similar to those in megakaryocytic leukemia (M7) may be present. Nuclei are round or irregular with lobulation and multinucleation.   

m6=1.jpg m6=2.jpg m6=3.jpg
   Example morphology of M6 blasts    Example morphology of M6 blasts    Example morphology of M6 blasts

Using the CD45 vs SSC gating dot plot, AML-M6 blasts will be CD45 negative (green).  Lymphoblasts, megakaryoblasts and plasma cells will also fall in this region and need to be excluded.                         

./CD45 SSC M6.jpg
     CD45 vs SSC dot plot from
a case of AML-M6

Below are selected dot plot examples of a AML-M6 case:          

./M613dr.jpg ./M634117.jpg ./M638.jpg
./M6195.jpg ./M66162.jpg ./M671GPHA.jpg
 HLA DR, CD13, CD19 and CD5
are not expressed
 CD34, CD117, CD61 and CD62p
are not expressed.
 Bright CD38 is not present. Glycophorin A and CD71 are expressed in this case.
Other relevant tests

Cytochemistry: The blasts are MPO negative, but often positive for NSE. The malignant red cells are PAS positive, (forming PAS positive lakes or containing coarse chunks of PAS positive material).

Genetics: Chromosome Abnormalities: 8+, -5, del(5q), and -7.                     


WHO recognizes two subtypes of AML-M6: erythroleukemia (erythroid/myeloid leukemia) and pure erythroid leukemia. Erythroleukemia is defined by > 50% erythroid precursors and > 20% myeloblasts.  Pure erythroid leukemia is defined by > 80% erythroid precursors.                            

Flow Diagnosis

Erythroblasts are positive for Glycophorin A (GPHA) and CD71. The erythroid component lacks MPO, CD34, CD45 and pan myeloid markers. CD117 and CD43 are often positive, when myeloblasts are present. 

Contributors to this page

Images (11)
Viewing 1 - 6 of 11 images | View All
No description
m6=3.jpg  Actions
No description
m6=2.jpg  Actions
No description
m6=1.jpg  Actions
No description
M613dr.jpg  Actions
No description
M638.jpg  Actions
No description
M634117.jpg  Actions
Comments (0)
You must login to post a comment.
Page last modified 18:39, 2 Dec 2014 by admin